Erkek Osteoporozu

Yıl 2019, Cilt: 11 Sayı: 3, 96 - 98, 03.05.2019

Burcu Önder

Öz

Osteoporoz kemik mineral yoğunluğunda azalma ve kemik kırılganlığında artış ile
seyreden metabolik bir kemik hastalığıdır. Beklenen yaşam süresinin uzaması osteoporozu
ciddi bir morbidite ve mortalite nedeni haline getirmektedir.

Anahtar Kelimeler

osteoporoz, erkekosteoporoz, erkek

Kaynakça

• 1. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical epidemiyology of male osteoporosis: a review of the recent literature. Clinical Epidemiyology 2015:7 65-76.
• 2. Sutton R AL, Dian L, Guy P. Osteoporosis in men: an underrecognized and undertreated problem. BC Medical Journal. 2011: 53 no: 10
• 3. Rosen CJ, Kurland ES, Vereault D et al. Association between serum insülin growth factor-1 (IGF-1) and a simple sequence repeat in IGF-1 gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998; 83: 2286- 2290
• 4. Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM, Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 2004; 89: 2286- 2290
• 5. Adler AA. Osteoporosis in men: a review. Bone research 2014:2 14001
• 6. Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporosis Int 2011;22:1845-1853
• 7. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2012;77: 453-468
• 8. Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009;94:1214- 22.
• 9. Papaioannou A,Morin S, Cheung AM et al. 2010 clinical practice guidelines fort he diagnosis and management of osteoporosis in Canada: Summary CMAJ 2010;182:1864-73
• 10. Orwoll E, Ettinger M,Weiss S et al. Alendronate for the treatment of osteoporosis in men. N Eng J Med 2000;343:604-10
• 11. Nayak S, Greesspan S. Osteoporosis treatment efficacy for men: a systematic review and meta-analysis. Journal of American Geriatrics Society 2016
• 12. Schoofs MW, van der Klift M, Hofman A et al. Thiazide diüretics and the risk for hip fracture. Ann Intern Med 2003;139:476-82.
• 13. Kaufman JM, Audran G, Bianchi G, Braga M et al.Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clini Endoc Metab 2013 Vol 98.
• 14. Smith MR, Egerdie B, Hernandez TN, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Eng J Med 2009;361:745-755